• $14.7M
    Market Cap
  • -63.33%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
510,000
-44.57%
920,000
+99.57%
461,000
+3,192.86%
14,000
0.00%
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
510,000
-44.57%
920,000
+99.57%
461,000
+3,192.86%
14,000
0.00%
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-6.8M
-68.44%
-21.6M
+135.35%
-9.2M
+229.66%
-2.8M
-57.56%
Depreciation and Amortization Expense
19,000
-5.00%
20,000
+233.33%
6,000
-70.00%
20,000
-58.33%
Total Operating Expenses
13.7M
-52.42%
28.8M
+81.35%
15.9M
-19.06%
19.6M
+28.30%
Operating Profit
-13.7M
-52.42%
-28.8M
+81.35%
-15.9M
-19.06%
-19.6M
+28.30%
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
N/A
0
N/A
0
N/A
0
N/A
Total Nonoperating Income and Expense
735,000
-39.61%
1.2M
-64.37%
3.4M
-39.66%
5.7M
+566,200.00%
Income before Taxes
-13.0M
-52.98%
-27.6M
+121.27%
-12.5M
-10.72%
-14.0M
-8.62%
Income Taxes
0
N/A
0
N/A
0
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-13.0M
-52.98%
-27.6M
+121.27%
-12.5M
-10.72%
-14.0M
-8.62%
Net Income from Continuing Operations Applicable to Common
-13.0M
-52.98%
-27.6M
+121.27%
-12.5M
-10.72%
-14.0M
-8.62%
Basic EPS and Net Income
-7.35
+106.46%
-3.56
+44.72%
-2.46
-54.70%
-5.43
+722.73%
Diluted EPS and Net Income
-7.35
+106.46%
-3.56
+44.72%
-2.46
-54.70%
-5.43
+722.73%
Basic Weighted Average Shares
1.8M
-77.23%
7.8M
+52.97%
5.1M
+97.04%
2.6M
-88.88%
Diluted Weighted Average Shares
1.8M
-77.23%
7.8M
+52.97%
5.1M
+97.04%
2.6M
-88.88%
Balance Sheet
Cash and Cash Equivalents
10.3M
-35.83%
16.0M
-28.61%
22.4M
-32.76%
33.4M
+103.60%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
10.3M
-35.83%
16.0M
-28.61%
22.4M
-32.76%
33.4M
+103.60%
Total Current Assets
10.9M
-32.34%
16.1M
-28.61%
22.5M
-32.86%
33.5M
+102.19%
Accumulated Depreciation
73,000
+35.19%
54,000
+58.82%
34,000
+21.43%
28,000
-74.77%
Property and Plant and Equipment and Net
17,000
-50.00%
34,000
-26.09%
46,000
+2,200.00%
2,000
-98.18%
Total Long-Term Assets
21,000
0.00%
21,000
0.00%
21,000
+950.00%
2,000
-98.18%
Total Assets
11.1M
-31.59%
16.3M
-28.62%
22.8M
-32.07%
33.5M
+99.62%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
5.6M
-31.71%
8.3M
+38.78%
6.0M
-49.42%
11.8M
+446.31%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
142,000
+144.83%
58,000
-57.35%
136,000
+202.22%
45,000
0.00%
Total Liabilities
5.8M
-30.48%
8.3M
+36.63%
6.1M
-48.27%
11.8M
+435.15%
Retained Earnings
-148.8M
+9.55%
-135.9M
+25.49%
-108.3M
+13.02%
-95.8M
+17.07%
Total Stockholders Equity
5.3M
-32.76%
7.9M
-52.47%
16.7M
-23.29%
21.8M
+49.00%
Total Shares Outstanding
2.3M
-73.27%
8.6M
+76.05%
4.9M
+452.05%
888,693
-96.67%
Cash Flow
Cash from Operating Activities
-15.7M
-36.46%
-24.7M
+128.82%
-10.8M
-7.80%
-11.7M
-22.61%
Capital Expenditures
2,000
-75.00%
8,000
-84.00%
50,000
+1,566.67%
3,000
0.00%
Cash from Investing Activities
-2,000
-75.00%
-8,000
-84.00%
-50,000
-725.00%
8,000
+101.37%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
10.0M
-45.55%
18.3M
+22,975.00%
-80,000
-100.28%
28.7M
+30.21%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
-2,687.84%
-14.17%
-3,131.41%
-9.13%
-3,445.99%
-97.54%
-140,200.00%
+28.30%
Return on Assets
-94.75%
-32.97%
-141.35%
+219.17%
-44.29%
-20.20%
-55.50%
-49.59%
Return on Equity
-195.61%
-12.74%
-224.18%
+245.48%
-64.89%
-15.57%
-76.85%
-45.19%
Revenue Growth
-44.57%
-144.76%
99.57%
-96.88%
3,192.86%
N/A
0.00%
+100.00%
Current Ratio
1.93
-0.91%
1.94
-48.55%
3.78
+32.74%
2.85
-62.99%
Cash Ratio
1.82
-6.03%
1.94
-48.56%
3.76
+32.95%
2.83
-62.73%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow